Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2575
1.68 %
$ 65.9 M
Market Cap
-0.81
P/E
ADAP - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity ADAP - Adaptimmune Therapeutics plc
246 M
LAST VALUE
-13.52%
2 YEAR CAGR
6.26%
5 YEAR CAGR
16.05%
10 YEAR CAGR